| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
ACHV
Achieve Life Sciences
|
Aug 12, 2026 | BUY |
Strong Buy
+115.2% avg upside
15 analysts
|
$13.00
94.33% Upside
|
· | · |
|
SRRK
Scholar Rock Holding
|
Aug 12, 2026 | BUY |
Strong Buy
+8.4% avg upside
23 analysts
|
$62.00
15.21% Upside
|
-3.0% | · |
|
JAZZ
Jazz Pharmaceuticals
|
Aug 11, 2026 | BUY |
Strong Buy
-4.1% avg upside
35 analysts
|
$300.00
20.47% Upside
|
-2.0% | · |
|
ANIP
ANI Pharmaceuticals
|
Aug 10, 2026 | HOLD |
Strong Buy
+36.6% avg upside
11 analysts
|
$90.00
19.79% Upside
|
-0.2% | · |
|
ADMA
ADMA Biologics
|
Aug 06, 2026 | BUY |
Strong Buy
+16.1% avg upside
15 analysts
|
$18.00
84.07% Upside
|
-7.0% | · |
|
AMGN
Amgen
|
Aug 05, 2026 | HOLD |
Buy
-24.4% avg upside
57 analysts
|
$384.00
7.80% Downside
|
+1.1% | · |
|
ABBV
AbbVie
|
Aug 03, 2026 | BUY |
Strong Buy
-4.0% avg upside
46 analysts
|
$290.00
16.56% Upside
|
+1.9% | · |
|
IONS
Ionis Pharmaceuticals
|
Jul 30, 2026 | BUY |
Strong Buy
+41.7% avg upside
43 analysts
|
$95.00
68.12% Upside
|
+6.9% | · |
|
ETON
Eton Pharmaceuticals
|
Jul 30, 2026 | BUY |
Strong Buy
-18.4% avg upside
9 analysts
|
$60.00
44.30% Upside
|
+15.7% | · |
|
PCRX
Pacira Pharmaceuticals
|
Oct 06, 2025 | HOLD |
Buy
+68.3% avg upside
21 analysts
|
— | +0.1% | · |
|
TSE:EPRX
Eupraxia Pharmaceuticals
|
Oct 02, 2025 | BUY |
Strong Buy
+140.4% avg upside
9 analysts
|
$16.73
84.11% Upside
|
+13.6% | · |
|
VERU
Veru
|
Aug 13, 2025 | BUY |
Strong Buy
+627.3% avg upside
10 analysts
|
$20.00
629.98% Upside
|
-31.7% | · |
|
INMB
Inmune Bio
|
Aug 04, 2025 | HOLD |
Buy
+494.6% avg upside
11 analysts
|
— | -33.2% | · |
|
LENZ
LENZ Therapeutics
|
Jul 31, 2025 | BUY |
Buy
+342.3% avg upside
17 analysts
|
$40.00
693.61% Upside
|
-82.2% | · |
|
AQST
Aquestive Therapeutics
|
Jun 17, 2025 | BUY |
Strong Buy
+110.4% avg upside
10 analysts
|
$7.00
65.56% Upside
|
+32.2% | · |
|
BLCO
Bausch + Lomb Corporation
|
Feb 20, 2025 | BUY |
Buy
+17.5% avg upside
19 analysts
|
$22.00
31.26% Upside
|
+12.9% | · |
|
ALNY
Alnylam Pharma
|
Jan 15, 2025 | BUY |
Strong Buy
+42.7% avg upside
51 analysts
|
$298.00
33.07% Upside
|
+43.1% | · |
|
SLGL
Sol-Gel Technologies
|
Aug 19, 2024 | BUY |
Strong Buy
+40.2% avg upside
6 analysts
|
$4.00
94.44% Downside
|
+277.5% | · |
|
EVLO
Evelo Biosciences
|
Mar 16, 2023 | BUY |
Buy
+44999899.9% avg upside
5 analysts
|
$100.00
99999899.96% Upside
|
· | · |
|
AMRX
Amneal Pharmaceuticals
|
Mar 02, 2023 | HOLD |
Strong Buy
+2.4% avg upside
18 analysts
|
$4.00
77.42% Downside
|
+174.9% | · |
|
SDGR
Schrodinger
|
Mar 01, 2023 | BUY |
Strong Buy
+53.0% avg upside
14 analysts
|
$78.00
318.59% Upside
|
+9.0% | · |
|
PHAT
Phathom Pharmaceuticals
|
Mar 01, 2023 | BUY |
Strong Buy
+188.6% avg upside
14 analysts
|
$30.00
227.09% Upside
|
+18.6% | · |
|
VTRS
Viatris
|
Feb 27, 2023 | HOLD |
Buy
+46.3% avg upside
21 analysts
|
$14.00
13.13% Downside
|
+23.8% | · |
|
TSE:BHC
Bausch Health Companies
|
Feb 24, 2023 | HOLD |
Buy
+558.6% avg upside
29 analysts
|
$13.95
61.72% Upside
|
-4.8% | · |
|
ABCL
AbCellera Biologics
|
Feb 22, 2023 | BUY |
Strong Buy
+49.5% avg upside
15 analysts
|
$32.00
209.11% Upside
|
-44.8% | · |
|
TEVA
Teva Pharmaceutical
|
Feb 08, 2023 | HOLD |
Buy
-17.4% avg upside
39 analysts
|
$10.00
72.75% Downside
|
+21.9% | · |
|
RIGL
Rigel
|
Jan 09, 2023 | BUY |
Strong Buy
-40.3% avg upside
17 analysts
|
$3.00
92.88% Downside
|
-2.8% | · |
|
NMTRQ
9 Meters Biopharma
|
Nov 10, 2022 | BUY |
Buy
+3234374900.0% avg upside
11 analysts
|
$35.00
3499999900.06% Upside
|
· | · |
|
PYPD
PolyPid
|
Aug 11, 2022 | BUY |
Strong Buy
+231.3% avg upside
7 analysts
|
$25.00
416.59% Upside
|
· | · |
|
XCUR
Exicure
|
Aug 02, 2021 | BUY |
Buy
+7166.6% avg upside
4 analysts
|
$180.00
13746.21% Upside
|
· | · |
|
TRVI
Trevi Therapeutics
|
May 14, 2021 | BUY |
Strong Buy
+32.8% avg upside
18 analysts
|
$12.00
32.41% Downside
|
+7.3% | · |
|
AMPH
Amphastar Pharmaceuticals
|
May 11, 2020 | HOLD |
Hold
+27.3% avg upside
11 analysts
|
$21.00
5.16% Upside
|
-1.0% | · |
|
SNNAQ
Sienna Biopharmaceuticals
|
Sep 05, 2019 | BUY |
Buy
+299999900.0% avg upside
2 analysts
|
$3.00
299999899.99% Upside
|
· | · |
|
SGPYY
Sage Group
|
Sep 14, 2017 | BUY |
Buy
+45.1% avg upside
4 analysts
|
$80.00
45.12% Upside
|
-19.7% | · |
|
ZBH
Zimmer Biomet Holdings
|
Apr 27, 2017 | BUY |
Buy
+15.1% avg upside
38 analysts
|
$138.00
40.92% Upside
|
-0.2% | · |
|
IRWD
Ironwood Pharma
|
Mar 21, 2016 | HOLD |
Buy
+190.3% avg upside
23 analysts
|
$14.00
224.05% Upside
|
+67.7% | · |
|
AMRN
Amarin
|
Oct 09, 2013 | HOLD |
Buy
-40.4% avg upside
18 analysts
|
$6.80
51.72% Downside
|
-84.4% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.